In a report released today, Yanan Zhu from Wells Fargo maintained a Buy rating on Arcturus Therapeutics (ARCT – Research Report), with a price target of $50.00. The company’s shares closed ...
SAN DIEGO (AP) — SAN DIEGO (AP) — Arcturus Therapeutics (ARCT) on Thursday reported a loss of $30 million in its fourth quarter. On a per-share basis, the San Diego-based company said it had a ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback